Literature DB >> 7322687

Neonatal manifestations of maternal phencyclidine (PCP) abuse.

A A Strauss, H D Modaniou, S K Bosu.   

Abstract

Two cases concerning newborn infants whose mothers used phencyclidine (PCP) during pregnancy are described. The neonatal symptoms of maternal PCP abuse were jitteriness, hypertonicity, vomiting, and one case of diarrhea. In both infants, PCP was detected in the urine during the first few days of life. Both infants were successfully treated with phenobarbital but they continued to remain jittery and slightly hypertonic following discontinuation of the therapy. In one case the infant was noted to be microcephalic. In the neonate, the symptoms of maternal PCP abuse are similar to the symptoms of narcotic withdrawal. The diagnosis of PCP effects in the neonate can be confirmed by urinalysis for the drug. The teratogenicity of PCP remains a possibility. The metabolism and treatment of PCP effects in the newborn need further clarification.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7322687

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

Review 1.  Neonatal congenital microvillus atrophy.

Authors:  N Pecache; S Patole; R Hagan; D Hill; A Charles; J M Papadimitriou
Journal:  Postgrad Med J       Date:  2004-02       Impact factor: 2.401

2.  Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.

Authors:  J E Polifka; J M Friedman
Journal:  Can Fam Physician       Date:  1991-09       Impact factor: 3.275

3.  Inhibition of calcium ATPase by phencyclidine in rat brain.

Authors:  M Pande; J A Cameron; P J Vig; S F Ali; D Desaiah
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

4.  Impact of intrauterine exposure to phencyclidine (PCP) and cocaine on neonates.

Authors:  F Rahbar; A Fomufod; D White; L S Westney
Journal:  J Natl Med Assoc       Date:  1993-05       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.